|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.555 USD | +0.65% |
|
+0.59% | -29.82% |
| Market Cap | 1.87B 1.62B 1.51B 1.39B 2.62B 178B 2.65B 17.71B 6.95B 88.81B 7.01B 6.86B 294B | P/E 2026 * |
-5.73x | P/E 2027 * | -6.16x |
|---|---|---|---|---|---|
| Enterprise Value | 1.49B 1.29B 1.2B 1.11B 2.09B 142B 2.11B 14.12B 5.54B 70.83B 5.59B 5.47B 235B | EV / Sales 2026 * |
28.3x | EV / Sales 2027 * | 16x |
| Free-Float |
99.07% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ocular Therapeutix, Inc.
| 1 day | +0.59% | ||
| 1 week | +0.59% | ||
| Current month | +4.28% | ||
| 1 month | -11.80% | ||
| 3 months | -12.26% | ||
| 6 months | -6.99% | ||
| Current year | -29.82% |
| 1 week | 8.15 |  | 8.79 |
| 1 month | 8.15 | | 10.94 |
| Current year | 6.23 | | 13.03 |
| 1 year | 6.23 | | 16.44 |
| 3 years | 2 | | 16.44 |
| 5 years | 2 | | 16.44 |
| 10 years | 2 | | 24.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pravin Dugel
CEO | Chief Executive Officer | 62 | 15/04/2024 |
Jason Robins
DFI | Director of Finance/CFO | 50 | 20/01/2026 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 49 | 20/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Warden
CHM | Chairman | 57 | 01/07/2019 |
| Director/Board Member | 78 | 05/11/2012 | |
Leslie Williams
BRD | Director/Board Member | 66 | 20/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/23/26 A | Sell | Executive/Senior Manager | 1,759 | 0.0008% | ||
| 2/23/26 A | Sell | Executive/Senior Manager | 2,810 | 0.0013% | ||
| 2/23/26 A | Sell | Chief Technology Officer | 3,057 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.59% | +0.59% | -31.84% | +95.41% | 1.87B | |
| +1.75% | +3.26% | +59.79% | +162.65% | 1,043B | |
| +0.05% | +1.29% | +51.89% | +49.69% | 621B | |
| -0.37% | -4.45% | +25.29% | +63.61% | 435B | |
| +0.43% | +3.59% | +47.26% | +38.23% | 361B | |
| +0.71% | -1.10% | +35.74% | +39.54% | 293B | |
| -1.31% | -6.49% | +7.60% | +9.26% | 251B | |
| -0.39% | +5.99% | +44.33% | +62.44% | 220B | |
| +0.04% | -11.38% | +1.30% | -46.26% | 201B | |
| +0.55% | +1.63% | +20.98% | +65.39% | 164B | |
| Average | +0.26% | -3.26% | +26.23% | +54.00% | 359.1B | |
| Weighted average by Cap. | +0.62% | -3.79% | +41.33% | +75.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 52.56M 45.52M 42.43M 39.03M 73.68M 5B 74.5M 499M 196M 2.5B 197M 193M 8.28B | 112M 97.33M 90.73M 83.44M 158M 10.69B 159M 1.07B 418M 5.35B 422M 413M 17.71B |
| Net income | -334M -289M -270M -248M -468M -31.75B -473M -3.17B -1.24B -15.89B -1.25B -1.23B -52.61B | -326M -282M -263M -242M -456M -30.96B -462M -3.09B -1.21B -15.49B -1.22B -1.2B -51.31B |
| Net Debt | -378M -327M -305M -281M -530M -35.94B -536M -3.59B -1.41B -17.98B -1.42B -1.39B -59.56B | -66M -57.16M -53.29M -49.01M -92.52M -6.28B -93.56M -626M -246M -3.14B -248M -242M -10.4B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/08/26 | $8.460 | -0.47% | 55,042 |
| 05/08/26 | $8.500 | -1.05% | 1,599,949 |
| 04/08/26 | $8.590 | +2.26% | 2,231,589 |
| 03/08/26 | $8.400 | +2.82% | 3,327,377 |
| 31/07/26 | $8.170 | -3.54% | 2,151,848 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OCUL Stock
Select your edition
All financial news and data tailored to specific country editions
